Fig. 2From: Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancerNuclear images of PC-3 PIP/flu tumor-bearing mice at 2 h and 15 h post injection of a 152Tb-PSMA-617 (PET/CT) and b 177Lu-PSMA-617 (SPECT/CT). PSMA+, PSMA-positive PC-3 PIP tumor; PSMA-, PSMA-negative PC-3 flu tumor; Bl, urinary bladderBack to article page